Prescriber
Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.
Current Issue
- Updated BTS guidelines for the management of CAP in adults
- Published online on Jan 05, 2010
- Recommended management of GORD in general practice
- Published online on Jan 05, 2010
- 11th annual NICE conference: innovation and value
- Published online on Jan 05, 2010
- A primary care initiative to support medicines reconciliation
- Published online on Jan 05, 2010
- Head lice infestation: diagnosis and recommended management
- Published online on Jan 05, 2010
Supplements
- Drug Utilisation Review: Rivaroxaban - An orally active direct factor Xa inhibitor
- Published on Jan 16, 2009
To download the supplement please click on the title above
Click Here for more supplementsLatest News
- Sitagliptin with insulin
- Published on Dec 05, 2009
MSD’s DPP-4 inhibitor sitagliptin (Januvia) has been approved as ‘add-on to insulin (with or without metformin) when diet and exercise...
- No increased cancer risk with anti-TNFs
- Published on Dec 05, 2009
A Swedish observational study has found no overall increase in cancer risk with anti-TNF agents after six years’ treatment of rheumatoid...
- EMEA begins review of sibutramine safety
- Published on Dec 05, 2009
The European Medicines Agency (www.emea.europa. eu) is reviewing the safety of the antiobesity drug sibutramine (Reductil) following new concerns...
ASK PRESCRIBER
Do you have a question that you would like our specialists and prescribing experts to answer? Click here to send us your query.
How to explain the long-term osteoporosis risk to teenagers for Depo-Provera?
What is the current state of play with depot medroxyprogesterone acetate (DMPA; Depo-Provera) and the risk of long-term osteoporosis? How do we explain this to all the feckless 15 year olds for who it is the only thing that seems to work?
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- New Product Reviews
- Learning Central
- Ask Prescriber
- Forthcoming Events
- Supplements
- Useful Websites






